Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Provectus Biopharmaceuticals's enterprise value was $19.38M on Oct 19, 2026, against $29.86M a year earlier. Over the last 5 years it ranged from $19.38M to $82.99M, with a median of $36.39M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $19.38M | -17.3% |
| 2025 | Dec 31, 2025 | $23.43M | -53.4% |
| 2024 | Dec 31, 2024 | $50.29M | +26.0% |
| 2023 | Dec 29, 2023 | $39.91M | -11.8% |
| 2022 | Dec 30, 2022 | $45.24M | +98.3% |
| 2021 | Dec 31, 2021 | $22.82M | +3.4% |
| 2020 | Dec 31, 2020 | $22.07M | -8.2% |
| 2019 | Dec 31, 2019 | $24.05M | +26.9% |
| 2018 | Dec 31, 2018 | $18.94M | -37.3% |
| 2017 | Dec 29, 2017 | $30.19M | – |
| 2016 | Dec 30, 2016 | -$300.17K | -100.5% |
| 2015 | Dec 31, 2015 | $60.92M | -51.8% |
| 2014 | Dec 31, 2014 | $126.47M | -61.6% |
| 2013 | Dec 31, 2013 | $329.08M | +447.6% |
| 2012 | Dec 31, 2012 | $60.09M | -23.0% |
| 2011 | Dec 30, 2011 | $78.00M | – |
See a number that looks wrong?